A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery

British Journal of Plastic Surgery

Volumn 54, Issue 1, 2001, Pages 1-7

  O'Toole, Greg ^a   MacKenzie, Duncan ^a   Poole, Michael ^a   Buckley, Michael F ^b   Lindeman, Rob ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Gene therapy; Plastic surgery; Therapeutic angiogenesis; VEGF

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; AMINO ACID; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CELL RECEPTOR; CELL SURFACE RECEPTOR; DNA; ENDOTHELIAL CELL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROTEIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; POLYPEPTIDE; RECOMBINANT GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; SOMATOMEDIN A; SOMATOMEDIN B; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG INDICATION; GENE THERAPY; HEART MUSCLE ISCHEMIA; LEG ISCHEMIA; MEDICAL LITERATURE; MEDICAL RESEARCH; MOUSE; NONHUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; RAT; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING; VASCULARIZATION;

EID: 0035168220     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.2000.3454     Document Type: Review

References (76)

1. Molecular and biological properties of the vascular endothelial growth factor family of proteins
2. Therapeutic angiogenesis: Protein and gene therapy delivery strategies
3. Gene therapy for collateral vessel development
4. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice
5. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
6. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
7. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
8. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
9. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
10. Suppression of solid tumor growth by immunoneutralizing monoclonal antibodies against human basic fibroblast growth factor
11. Vascular permeability factor: A unique regulator of blood vessel function
12. Significance of angiogenesis in cancer therapy
13. The vascular endothelial growth factor family of polypeptides
14. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
15. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
16. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
17. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
18. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
19. Mutations in the vascular endothelial growth factor receptor (VEGFR-3; Flt4) cause hereditary lymphedema
20. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
21. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
22. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
23. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
24. VEGFs, receptors and angiogenesis
25. Heterodimers of placenta growth factor/vascular endothelial growth factor: Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
26. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
27. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor
28. Fibroblast growth factors
29. Growth factors and wound healing: Role in normal and chronic wound healing
30. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
31. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice
32. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue
33. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice
34. Transforming growth factors β
35. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils
36. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
37. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture
38. PDGF and FGF stimulate wound healing in the genetically diabetic mouse
39. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
40. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat
41. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat
42. The effects of VEGF on survival of a random flap in the rat: Examination of various routes of administration
43. Accelerated flap prefabrication with vascular endothelial growth factor
44. Augmentation of skeletal muscle flap survival using platelet derived growth factor
45. Coadministration of basic fibroblast growth factor and sucrose octasulfate (sucralfate) facilitates the rat dorsal flap survival and viability
46. The effect of basic fibroblast growth factor on the neovascularisation process: Skin flap survival and staged flap transfers
47. Local infiltration of an angiogenic growth factor does not stimulate the delay phenomenon
48. Stimulation of angiogenesis to improve the viability of prefabricated flaps
49. Autologous facial fat transplantation: Improved graft maintenance by microbead bioactivation
50. Free bone graft reconstruction of irradiated facial tissue: Experimental effects of basic fibroblast growth factor stimulation
51. Investigation of acidic fibroblast growth factor delivered through a collagen scaffold for the treatment of full-thickness skin defects in a rabbit model
52. Improved vitality of experimental random dorsal skin flaps in rats treated with enriched cell culture medium
53. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
54. Utilizing angiogenic agents to expedite the neovascularization process in skin flaps
55. Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing
56. Effects of activated macrophages and fibroblast growth factor on random skin flap survival in swine
57. Enhancement of wound healing by topical treatment with epidermal growth factor
58. Epidermal and dermal effects of epidermal growth factor during wound repair
59. Angiogenic revascularisation in ischaemic disease: Molecular techniques hold promise, though they are still some way off
60. Constant delivery of proinsulin by encapsulation of transfected cells
61. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
62. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
63. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon
64. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
65. Angiogenesis gene therapy: Phase 1 assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
66. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps
67. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
68. Clinical applications and technical limitations of prefabricated flaps
69. The development of neovascularisation in flap prefabrication with vascular implantation: An experimental study
70. Total mandibular and lower lip reconstruction with a prefabricated osteocutaneous free flap
71. Mode of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flaps
72. The value of the delay phenomenon in flap prefabrication: An experimental study in rabbits
73. A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbits
74. Vascular endothelial growth factor expression in expanded tissue: A possible mechanism of angiogenesis in tissue expansion
75. The use of negative pressure to promote the healing of tissue defects: A clinical trial using the vacuum sealing technique
76. Vacuum assisted closure: A new method for wound control and treatment: Clinical experience